Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Pelletier

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
Journal for Immunotherapy of Cancer|November 29, 2023
Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumorsTodd M Bauer, Armando Santoro, Chia-Chi Lin, et al.
Immunotherapy Advances|October 5, 2022
Characterization of sabatolimab, a novel immunotherapy with immuno-myeloid activity directed against TIM-3 receptorStephanie Schwartz, Nidhi Patel, Tyler Longmire, et al.
Gastroenterology|June 1, 2023
Transforming Growth Factor-β Blockade in Pancreatic Cancer Enhances Sensitivity to Combination ChemotherapyLi Qiang, Megan T Hoffman, Lestat R Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2022
Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib StudyFunda Meric-Bernstam, Randy F Sweis, Stefan Kasper, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 25, 2026
Randomized, Sham-Controlled Trial of Intraoperative Ticagrelor Removal to Reduce Perioperative BleedingMichael J Mack, Richard Whitlock, Michael W A Chu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2023
cIAP1/2 Antagonism Induces Antigen-Specific T Cell-Dependent ImmunityKatherine S Ventre, Kevin Roehle, Elisa Bello, et al.
Heart (British Cardiac Society)|August 19, 2016
Transcatheter aortic valve implantation in patients with small aortic annuli using a 20 mm balloon-expanding valveRishi Puri, Jonathan Byrne, Ralf Muller, et al.
Molecular Cancer Research : MCR|August 31, 2017
Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based SubtypesLi Zhang, Kenzie D MacIsaac, Ting Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2026
Biomarker analysis from patients with metastatic PDAC treated with TGFβ antibody, NIS793, plus abraxane+gemcitabine vs. abraxane+gemcitabine alone in a phase II, open label, randomized studyMarc Pelletier, Jie Yang, Mukta Joshi, et al.
The Annals of Thoracic Surgery|January 31, 2026
Society of Thoracic Surgeons Expert Consensus Pathway for Robotic Cardiac Surgical TrainingVinay Badhwar, Arman Arghami, Štěpán Černý, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Journal for Immunotherapy of Cancer|November 29, 2023
Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumorsTodd M Bauer, Armando Santoro, Chia-Chi Lin, et al.
Immunotherapy Advances|October 5, 2022
Characterization of sabatolimab, a novel immunotherapy with immuno-myeloid activity directed against TIM-3 receptorStephanie Schwartz, Nidhi Patel, Tyler Longmire, et al.
Gastroenterology|June 1, 2023
Transforming Growth Factor-β Blockade in Pancreatic Cancer Enhances Sensitivity to Combination ChemotherapyLi Qiang, Megan T Hoffman, Lestat R Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2022
Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib StudyFunda Meric-Bernstam, Randy F Sweis, Stefan Kasper, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 25, 2026
Randomized, Sham-Controlled Trial of Intraoperative Ticagrelor Removal to Reduce Perioperative BleedingMichael J Mack, Richard Whitlock, Michael W A Chu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2023
cIAP1/2 Antagonism Induces Antigen-Specific T Cell-Dependent ImmunityKatherine S Ventre, Kevin Roehle, Elisa Bello, et al.
Heart (British Cardiac Society)|August 19, 2016
Transcatheter aortic valve implantation in patients with small aortic annuli using a 20 mm balloon-expanding valveRishi Puri, Jonathan Byrne, Ralf Muller, et al.
Molecular Cancer Research : MCR|August 31, 2017
Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based SubtypesLi Zhang, Kenzie D MacIsaac, Ting Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2026
Biomarker analysis from patients with metastatic PDAC treated with TGFβ antibody, NIS793, plus abraxane+gemcitabine vs. abraxane+gemcitabine alone in a phase II, open label, randomized studyMarc Pelletier, Jie Yang, Mukta Joshi, et al.
The Annals of Thoracic Surgery|January 31, 2026
Society of Thoracic Surgeons Expert Consensus Pathway for Robotic Cardiac Surgical TrainingVinay Badhwar, Arman Arghami, Štěpán Černý, et al.
Pageof 12